TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Feronia Inc. (“Feronia” or the “Company”) (TSX-V: FRN) today announces the appointment of Jean Habay to its board of directors (the “Board”) as a non-executive director nominated by CDC Group PLC (“CDC”).
Mr. Habay joined CDC in January 2016 as a director in its equity investments team. Prior to CDC he spent ten years as a senior member of the private equity team of Swicorp, a financial services firm focused on the Middle East and Africa, managing over US$1 billion in funds. Prior to Swicorp, Mr. Habay acquired a wealth of transactional, strategic and operational experience, first as a consultant at McKinsey & Company and then at Salomon Smith Barney and Capital One. He is a graduate of Ecole Centrale Paris and has an MBA from Northwestern University’s Kellogg School of Management.
Frank Braeken, Chairman of Feronia commented: “Jean is a great addition to the Board. Not only does he come with a wealth of business and private equity experience, as importantly he comes with a wide and relevant perspective of the agro and foods opportunities in Africa.”
The above noted appointment to the Board is subject to the approval of the TSX Venture Exchange.
For further information please contact:
Xavier de Carniere Chief Executive Officer, Feronia Inc. 44 (0)7468 697 658 xavier.decarniere@feronia.com www.feronia.com | Paul Dulieu Director of Communications and Corporate Development, Feronia Inc. 44 (0)7554 521421 paul.dulieu@feronia.com www.feronia.com |
About Feronia Inc.
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.